Toradol and Naftin drug interactions - a phase IV clinical study of FDA data

Summary:

The phase IV clinical study analyzes what interactions people have when they take Toradol and Naftin. It is created by eHealthMe based on reports of 1 person who takes the same drugs from the FDA, and is updated regularly.

What is Toradol?

Toradol has active ingredients of ketorolac tromethamine. It is often used in pain. eHealthMe is studying from 9,230 Toradol users. Check the latest studies of Toradol.

What is Naftin?

Naftin has active ingredients of naftifine hydrochloride. eHealthMe is studying from 377 Naftin users. Check the latest studies of Naftin.



On Jul, 11, 2026

1 person who takes Toradol and Naftin together, and has interactions is studied.

Toradol and Naftin drug interactions.

What are the common drug interactions of Toradol and Naftin, by gender? *:

female:

  1. Activities of daily living impaired
  2. Anaemia (lack of blood)
  3. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  4. Dumping syndrome (a condition that can develop after surgery to remove all or part of your stomach or after surgery to bypass your stomach to help you lose weight)
  5. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
  6. Fibromyalgia (a long-term condition which causes pain all over the body)
  7. Gait disturbance
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Headache (pain in head)
  10. Hyperlipidaemia (presence of excess lipids in the blood)

male:

n/a

What are the common drug interactions of Toradol and Naftin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Activities of daily living impaired
  2. Anaemia (lack of blood)
  3. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  4. Dumping syndrome (a condition that can develop after surgery to remove all or part of your stomach or after surgery to bypass your stomach to help you lose weight)
  5. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
  6. Fibromyalgia (a long-term condition which causes pain all over the body)
  7. Gait disturbance
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Headache (pain in head)
  10. Hyperlipidaemia (presence of excess lipids in the blood)

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Toradol and Naftin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Toradol and Naftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Toradol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Toradol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naftin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ketorolac tromethamine and naftifine hydrochloride (the active ingredients of Toradol and Naftin, respectively), and Toradol and Naftin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: